Elevian

Generation Lab recruits longevity influencers into a private cohort for a drug it won't name

The offer bundled the treatment with the write-up about it. The evidence so far is a spreadsheet of insider self-reports, and the hundred-person study the company plans will ask its subjects to pay to enroll.